Clinical Trial Update: Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients [NA]

View source ↗

Summary

A clinical trial evaluating intravenous continuous infusion heparin to reduce venous thromboembolism in high-risk, critically ill patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: NYU Langone Health | Conditions: Venous Thromboembolism | NA | Status: WITHDRAWN